openPR Logo
Press release

11th International Conference on Vascular Dementia

10-16-2018 09:41 AM CET | Health & Medicine

Press release from: Europe Conference

Vascular Dementia 2019

Vascular Dementia 2019

Can We Cure Dementia, Vascular Dementia and Alzheimer's disease?
It’s our pleasure to invite all the participants from all over the world to attend the 11th International Conference on Vascular Dementia which is held during February 15-16, 2019 Amsterdam| Netherlands.
Vascular Dementia conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Neuroscience researchers from both academic and health care professionals will join this event to discuss their views and research. The Neurology event will be organized by world Neuroscience and Neurology experts for conducting symposiums, B2B meetings, and workshops will also be conducted on the field of Vascular Dementia, Alzheimer's disease and Aging.
Effective content from Market Analysis:
Why Amsterdam:
Neurodegenerative disorders, particularly Alzheimer’s disease (AD), other forms of dementia and Parkinson’s disease (PD), are among the biggest health care challenges of the 21st century. There are now over 250,000 dementia patients and 40,000 patients of Parkinson’s disease in the Netherlands. Because no treatments can stop these neurodegenerative disorders amid the backdrop of an aging population, numbers are expected to rise further quickly. This poses a direct threat to the sustainability of our entire health care system. The development of treatments that stop, prevent or at least slow down the degenerative processes is crucial to reduce future costs associated with neurodegenerative disorders and hence keep our health care system viable.
Tourist Attraction:
Amsterdam is the Netherlands’ capital it has a population of about 851,373 within the city proper, and 1,351,587 in the urban area and 2,410,960 in the Amsterdam metropolitan area. As per the period of 2010–2012, annually 34,681 patients visited the ED due to the TBI, comprising about 4% of the total injury-related ED visits per year in Netherlands. The overall incidence rate of ED visits due to TBI was 213.6 per 100,000 person years, 241.9 for males, 175.3 for females. Incidence rates were highest in children 268.2, young adults 271.6 and older patients 75–84 years 307.6 or 85 and older 578.2. The estimated total costs of TBI in Netherlands were about €314.6 million per year.
Conference Highlights
• Dementia
• Vascular Dementia
• Lewy body Dementia
• Amyloid Imaging in Dementia
• Alzheimers Disease
• Neurodegenerative Diseases
• Brain Diseases
• Ageing and Dementia
• Dementia Care Management
• Dementia Nursing
• Treating Dementia
• Neuropharmacology
• Novel Therapeutics
• Animal Models in Dementia
• Neuro Oncology and CNS

This live event is looking for new approaches and scopes to thoroughly review the scientific as well as clinical aspect of addiction. Join with more than 500 colleagues for interactive, innovative and incredible experience in beautiful city of Amsterdam, Netherlands

Learning Objectives

1. Share and describe new developments in the field of dementia
2. They can compare research guidelines and good practices with new current practices and strength or gaps
3. Discover new research techniques in development with practical implication used in recovery treatment or research fields
4. Participants can build their networks of professionals and can find valuable resources
5. Explain recent or upcoming changes in policy to identify provider involvement areas
6. Demonstrate the knowledge while treating patients with Alzheimer's disease in clinical aspects
7. Usage of various patient screening tools that used to identify usage of substance abuse and interpretation results
8. Enhance patient’s readiness to change in their risky behaviour’s by using motivational interviewing
9. Also will be offer referral in regards to behavioural interventions which include support groups as well as mutual groups that will assist in recovery process

Participation Benefits:

Welcome Reception
Keynote Presentation
Presentation over concurrent streams
Half day Workshop
Poster Presentation
Video/ Virtual Presentation
Exhibitor and Sponsor displays
Symposium and Networking
Best Poster Award
Young Researcher Award

Who Will Attend

We welcome all the participants from professionals as well as student and delegate whoever is dedicated in increasing the quality improvement in the field of Vascular Dementia, Alzheimer's disease and Aging, includes:

• Psychiatrist
• Neurologist
• Researchers
• Academics
• Recovery & Clinical Service Managers
• Occupational Therapist
• Social Workers
• Therapy and Care Advisors
• Treatment Managers

Why to attend??
Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.
Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

International SUPPORTED Journals:

1. Journal of Alzheimers Disease & Parkinsonism
2. Journal of Neurological Disorders
3. Brain Disorders & Therapy

Website: https://vasculardementia.conferenceseries.com/

Direct Call: +44 203-936-3178

Europe Conference meetings International is the world’s leading specialist in organizing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine.

Rose Watson | Program Manager
Vascular Dementia 2019 | Neuroscience Conferences
47 Churchfield Road, London, W3 6AY
Tel: +44-203-936-3178

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 11th International Conference on Vascular Dementia here

News-ID: 1305219 • Views: 1215

More Releases for Dementia

2nd International Conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the
2nd International conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the
Global Alzheimer’s disease, Dementia and Ageing Awareness
Lexis brings in a new spin on conferences by presenting the latest scientific improvements in the fields of Neurology and Neuroscience. Zurich is all set for an amazing event as LEXIS proudly presents the “Global Alzheimers, Dementia and Ageing Awareness” slated on July 17-18, 2019 at Zurich, Switzerland. The theme of the conference is “Global Voice and Awareness on Alzheimers Disease and Dementia Care”. Avenue Roger VAndendriessche, 18 at 1150 BRUSSELS Avenue
Dementia Market -Pipeline Review, H1 2018: MarketResearchReports.biz
"The Latest Research Report Dementia-Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline Review, H1 2018, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with
Dementia - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Dementia - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline Review, H2 2017, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with
Dementia from an art and design perspective
Demographic change requires a new approach to dementia. A project supported by the Austrian Science Fund FWF creates awareness of the issue using innovative artistic methods that sharpen the perception and sensitivity of people unaffected by the ailment. Dementia patients often suffer from social stigma. Everyday errands such as shopping, financial transactions or going to the theatre may be difficult for them, so they withdraw from society in order to avoid